Eli Lilly and Company (LLY) added 0.64% on November 5, 2026, with shares trading at $1,418.44. The single-session gain extended a rally that has gathered considerable force over recent weeks.
Over the past seven days, LLY has climbed 10.05%, reflecting sustained buying pressure across a broader short-term window. The 30-day performance is more striking, with shares up 23.98% over that span.
The pharmaceutical giant's market capitalization stood at $1,255.4 billion as of the close, reflecting its standing as one of the largest companies by that measure in the market.
The combination of near-term and medium-term gains places Eli Lilly among the stronger performers in its category over the measured periods, according to available price data.
